Here is what Google says, though may not support the 80% market share assertion:
https://www.mckinsey.com/industries/life-sciences/our-insights/pharmas-first-to-market-advantage
https://web-assets.bcg.com/img-src/What_Matters_Most_Biopharma_tcm9-95831.pdf - see this interesting table from this article. The FIC & BIC have an opportunity in the left column in green, reaching almost 100%.
RAC media coverage, page-1117
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.64 |
Change
0.070(4.46%) |
Mkt cap ! $269.7M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.64 | $1.58 | $141.5K | 87.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 800 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 2745 | 1 |
View Market Depth
| Last trade - 13.01pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.66 |
Change
0.070 ( 5.77 %) |
||||
| Open | High | Low | Volume | ||
| $1.60 | $1.66 | $1.58 | 5136 | ||
| Last updated 13.11pm 06/06/2024 ? | |||||
| RAC (ASX) Chart |